Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘15 |
|
|---|---|---|---|---|---|
| $37M | $147M | $110M | 686% |
|
|
| $36.6M | $130M | $93.6M | 52.8% |
|
|
| $36.5M | $69.9M | $33.4M | 135% |
|
|
204
Neurocrine Biosciences
NBIX
$12.9B
| $36.2M | $65M | $28.8M | 224% |
|
| $36.2M | $78.9M | $42.8M | 91.4% |
|
|
| $36M | $101M | $65.1M | 25.8% |
|
|
| $35.8M | $40.5M | $4.73M | 153% |
|
|
| $35.4M | $38.3M | $2.9M | 543% |
|
|
| $34.3M | $97.2M | $62.9M | 150% |
|
|
| $33M | $48.5M | $15.5M | 1,009% |
|
|
211
ProShares UltraShort S&P500
SDS
$498M
| $32.1M | $64M | $31.9M | 97% |
|
| $31.3M | $31.7M | $378K | 399% |
|
|
| $31.1M | $105M | $74M | 444% |
|
|
| $31M | $233M | $202M | 652% |
|
|
| $31M | $429M | $398M | 93.8% |
|
|
| $31M | $31.9M | $928K | 1,173% |
|
|
| $30.7M | $41.4M | $10.7M | 64.9% |
|
|
| $30.7M | $75.6M | $44.9M | 3.68% |
|
|
| $30.3M | $56.8M | $26.5M | 372% |
|
|
| $30.2M | $30.2M | $0 | 8.83% |
|
|
| $30M | $133M | $103M | 157% |
|
|
| $29.7M | $71.6M | $41.8M | 260% |
|
|
| $29.4M | $190M | $161M | 381% |
|
|
| $29.3M | $112M | $83M | 84% |
|
|
| $28.8M | $50.3M | $21.5M | 212% |
|